As the 73rd World Health Assembly opened on Monday 18 May, several organisations argued that the future vaccine developed to fight Covid-19 should not be protected by a patent that would give a monopoly to the big pharmaceutical groups.
Asked by EUROPE about this issue at an online conference organised by the European Policy Centre (EPC), Bart van Zijll Langhout, Vice-President of Strategic Alliances EMEA & Janssen, speaking on behalf of Johnson & Johnson, rejected the idea: "We all agree...